Jonathan Violin's Insider Trades & SAST Disclosures
Jonathan Violin's most recent trade in Astria Therapeutics Inc was a trade of 14,100 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 5, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jonathan Violin.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Astria Therapeutics Inc | Jonathan Violin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 14,100 | 14,100 | - | - | Stock Option (Right to Buy) | |
| Dianthus Therapeutics Inc | Jonathan Violin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 11,000 | 11,000 | - | - | Stock Option (Right to Buy) | |
| Astria Therapeutics Inc | Jonathan Violin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2023 | 14,100 | 14,100 | - | - | Stock Option (Right to Buy) | |
| Viridian Therapeutics Inc | Jonathan Violin | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2023 | 50,000 | 239,205 | - | - | Stock Option (Right to Buy) | |
| Viridian Therapeutics Inc | Jonathan Violin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 36.80 per share. | 02 Feb 2023 | 50,000 | 480,905 (1%) | 0% | 36.8 | 1,840,000 | Common Stock |
| Viridian Therapeutics Inc | Jonathan Violin | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.15 per share. | 02 Feb 2023 | 50,000 | 530,905 (1%) | 0% | 0.2 | 7,500 | Common Stock |
| Viridian Therapeutics Inc | Jonathan Violin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 36.80 per share. | 02 Feb 2023 | 50,000 | 430,905 (1%) | 0% | 36.8 | 1,840,000 | Common Stock |
| Astria Therapeutics Inc | Jonathan Violin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 8,333 | 8,333 | - | - | Stock Option (right to buy) | |
| Viridian Therapeutics Inc | Jonathan Violin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 12.20 per share. | 01 Jun 2022 | 30,000 | 480,905 (1%) | 0% | 12.2 | 366,000 | Common Stock |
| Viridian Therapeutics Inc | Jonathan Violin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.04 per share. | 02 May 2022 | 30,000 | 510,905 (1%) | 0% | 13.0 | 391,200 | Common Stock |
| Viridian Therapeutics Inc | Jonathan Violin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 18.92 per share. | 01 Apr 2022 | 26,400 | 544,505 (1%) | 0% | 18.9 | 499,488 | Common Stock |
| Viridian Therapeutics Inc | Jonathan Violin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 18.93 per share. | 01 Apr 2022 | 3,600 | 540,905 (1%) | 0% | 18.9 | 68,148 | Common Stock |
| Viridian Therapeutics Inc | Jonathan Violin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 17.82 per share. | 01 Mar 2022 | 18,894 | 582,011 (1%) | 0% | 17.8 | 336,691 | Common Stock |
| Viridian Therapeutics Inc | Jonathan Violin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 17.36 per share. | 01 Mar 2022 | 11,106 | 570,905 (1%) | 0% | 17.4 | 192,800 | Common Stock |
| Viridian Therapeutics Inc | Jonathan Violin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 280,000 | 280,000 | - | - | Stock Option (Right to Buy) | |
| Viridian Therapeutics Inc | Jonathan Violin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 19.55 per share. | 01 Feb 2022 | 16,751 | 614,154 (1%) | 0% | 19.5 | 327,482 | Common Stock |
| Viridian Therapeutics Inc | Jonathan Violin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 18.47 per share. | 01 Feb 2022 | 12,340 | 601,814 (1%) | 0% | 18.5 | 227,920 | Common Stock |
| Viridian Therapeutics Inc | Jonathan Violin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 19.16 per share. | 01 Feb 2022 | 909 | 600,905 (1%) | 0% | 19.2 | 17,416 | Common Stock |
| Astria Therapeutics Inc | Jonathan Violin | Director | Other type of transaction at price $ 0.00 per share. | 20 Sep 2021 | 263,321 | 263,321 (0%) | 0% | 0 | Common Stock | |
| Astria Therapeutics Inc | Jonathan Violin | Director | Other type of transaction at price $ 0.00 per share. | 20 Sep 2021 | 263,321 | 0 (0%) | 0% | 0 | Common Stock | |
| Astria Therapeutics Inc | Jonathan Violin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 85,000 | 85,000 | - | - | Stock Option (right to buy) | |
| Astria Therapeutics Inc | Jonathan Violin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Viridian Therapeutics Inc | Jonathan Violin | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2021 | 800,075 | 800,075 | - | - | Employee Stock Option (right to buy) | |
| Viridian Therapeutics Inc | Jonathan Violin | President and COO | Other type of transaction at price $ 0.00 per share. | 27 Oct 2020 | 4,338,079 | 4,338,079 | - | - | Employee Stock Option (Right to Buy) | |
| Viridian Therapeutics Inc | Jonathan Violin | President and COO | Other type of transaction at price $ 0.00 per share. | 27 Oct 2020 | 50,124 | 50,124 (0%) | 0% | - | Common Stock | |
| Viridian Therapeutics Inc | Jonathan Violin | President and COO | Other type of transaction at price $ 0.00 per share. | 27 Oct 2020 | 9,413 | 9,413 | - | - | Series A Non-Voting Convertible Preferred Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges